A Randomized, Masked, Placebo-Controlled Study of Darbepoetin Alfa in Preterm Infants

Abstract

Infants receiving Darbe or Epo received fewer transfusions and fewer donor exposures, and fewer injections were given to Darbe recipients. Darbepoetin and Epo successfully serve as adjuncts to transfusions in maintaining red cell mass in preterm infants.